Venous Thrombosis

Search with Google Search with Bing
Information
Disease name
Venous Thrombosis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00005504 Active, not recruiting Epidemiology of Venous Thrombosis and Pulmonary Embolism February 1998 April 2030
NCT03945045 Active, not recruiting N/A A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD May 21, 2019 January 2024
NCT04724460 Active, not recruiting Phase 4 Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer February 18, 2021 December 31, 2024
NCT04349189 Active, not recruiting Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait September 1, 2020 October 15, 2026
NCT00185952 Completed N/A Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor. November 2001 August 2008
NCT00203580 Completed Phase 4 Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) December 1994 March 2002
NCT00203658 Completed Phase 4 Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin April 1997 October 2000
NCT00211146 Completed Phase 3 A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) April 1998 May 2006
NCT00244270 Completed Phase 4 Cystic Fibrosis and Totally Implantable Vascular Access Devices December 2005 March 2009
NCT00246025 Completed Phase 2 A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. October 2005
NCT00265993 Completed Phase 4 Enoxaparin in Acute Venous Thromboembolic Disease December 2004 January 2009
NCT00306254 Completed Phase 2 Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery March 2006 July 2007
NCT00322270 Completed Phase 3 Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters January 2006
NCT00346424 Completed Phase 3 Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters September 2005 December 2006
NCT00351663 Completed Phase 4 The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients February 2007 September 2015
NCT00356759 Completed Phase 2 Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients December 2006 February 2010
NCT00395265 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome June 2006 December 2011
NCT00436787 Completed Phase 2 Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers February 2007 December 2007
NCT00440193 Completed Phase 3 Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study March 2007 April 2010
NCT00457002 Completed Phase 3 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness June 2007 May 2011
NCT00457158 Completed Phase 4 PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption July 2006 November 2012
NCT00535171 Completed Venous Thromboembolism Taskforce Audit Program June 2007
NCT00554632 Completed N/A Birth Control Pill vs Birth Control Patch Study April 2003 August 2005
NCT00585182 Completed Phase 4 Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT January 2007 April 2008
NCT00621491 Completed N/A Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation February 2004 July 2008
NCT00633893 Completed Phase 3 Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism May 2008 August 2012
NCT00643201 Completed Phase 3 Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism July 2008 March 2013
NCT00687882 Completed Phase 3 Evaluation of the Duration of Therapy for Thrombosis in Children March 2008 February 15, 2022
NCT00728819 Completed N/A Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters August 2008 August 2011
NCT00778336 Completed A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters January 2007 April 2010
NCT00786422 Completed Phase 2 Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer May 2009 June 2011
NCT00790335 Completed Phase 3 Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis November 2009 January 2017
NCT05890924 Completed Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women January 1, 2023 September 5, 2023
NCT00005684 Completed Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis March 1996 January 2001
NCT00097357 Completed Phase 2/Phase 3 BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery October 2004 December 2005
NCT00170378 Completed Phase 4 The Use of Low Molecular Weight Heparin in Traumatic Brain Injury December 2002 August 2005
NCT01662908 Completed Phase 2 A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis August 2012 March 2014
NCT01684423 Completed Phase 2 Oral Rivaroxaban in Children With Venous Thrombosis February 19, 2013 September 1, 2016
NCT01736826 Completed Free DNA and Nucleosome Concentrations in Pathological Pregnancies June 2015 December 17, 2018
NCT01779648 Completed N/A Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis March 2012 January 2013
NCT01805544 Completed Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication May 2013 June 2015
NCT01855100 Completed Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) July 2013 December 2014
NCT01857050 Completed Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins April 2013 January 2014
NCT01862471 Completed N/A Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow May 2013 June 2013
NCT01886612 Completed N/A A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Blood Flow June 2013 August 2013
NCT01894997 Completed N/A A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb January 2014 April 2014
NCT01947959 Completed Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) December 22, 2011 September 30, 2020
NCT01947985 Completed Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) February 1, 2012 September 30, 2020
NCT01947998 Completed Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) December 22, 2011 September 30, 2020
NCT01999179 Completed N/A Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis June 2014 April 26, 2022
NCT02064439 Completed Phase 3 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) March 5, 2014 November 4, 2016
NCT02065388 Completed Phase 3 Pharmacogenetic Dosing of Warfarin September 2009 December 2013
NCT02161965 Completed Phase 4 Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation May 21, 2013 February 16, 2018
NCT02247414 Completed Phase 4 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection September 2014 April 2018
NCT02258958 Completed Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection January 2014 December 2014
NCT02301793 Completed N/A Educating Nurses About Venous Thromboembolism (VTE) Prevention April 1, 2014 March 31, 2015
NCT02335580 Completed Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis December 2014 December 2022
NCT02468102 Completed Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) June 15, 2015 September 30, 2020
NCT02567903 Completed N/A Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System September 2015 June 2019
NCT02581176 Completed Phase 4 Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study April 2016 May 2018
NCT02584842 Completed Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy January 2012 December 2014
NCT02600260 Completed N/A Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial December 1, 2014 December 28, 2019
NCT02651909 Completed Utilization of TEG to Monitor Rivaroxaban Activity April 2016 November 4, 2019
NCT02867163 Completed Tranexamic Acid and Blood Clots in Knee Surgery May 16, 2017 November 8, 2017
NCT02892565 Completed N/A Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System) September 2005 December 2009
NCT03044574 Completed N/A Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism February 1, 2017 December 31, 2018
NCT03317145 Completed N/A Lower Limb Blood Flow Geko vs Foot Pump July 24, 2013 February 19, 2014
NCT03328624 Completed N/A A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff January 23, 2018 April 25, 2018
NCT03505723 Completed Phase 3 PeriOperative ISchemic Evaluation-3 Trial June 27, 2018 February 3, 2023
NCT03714048 Completed Blood Management During ECMO for Cardiac Support July 1, 2019 April 15, 2023
NCT03895502 Completed Phase 4 Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study May 27, 2019 August 31, 2023
NCT04339894 Completed Prospective Epidemiological Study of Upper Limb Venous Thrombosis August 4, 2020 January 12, 2023
NCT04645550 Completed Phase 4 Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT) November 22, 2020 March 31, 2023
NCT05304455 Completed N/A Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection April 1, 2022 May 31, 2023
NCT00839163 Completed Phase 2 Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) March 2004 October 2005
NCT00839657 Completed Phase 3 Clarification of Optimal Anticoagulation Through Genetics September 2009 November 2013
NCT00878826 Completed Phase 2/Phase 3 Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. May 2009 October 2014
NCT00986154 Completed Phase 3 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). October 2009 April 2013
NCT01086215 Completed Registry of AngioJet Use in the Peripheral Vascular System January 2010 September 2013
NCT01145859 Completed Phase 1 Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects November 2010 July 2015
NCT01240330 Completed N/A Vasculaire Compression System Increases Flow Velocity in the Femoral Vein August 2010 September 2010
NCT01297348 Completed Study Of Lybrel In Relation To Venous Thromboembolism July 2007 April 2012
NCT01317160 Completed N/A Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture March 2011 September 2018
NCT01354704 Completed Phase 4 Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin March 2011 October 2015
NCT01482273 Completed N/A Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis November 2011 November 2014
NCT01495429 Completed Phase 3 Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care January 2012 July 2015
NCT01507051 Completed Phase 1 Switching Study From Warfarin to Rivaroxaban November 2008 November 2009
NCT01608906 Completed N/A Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery May 2007 May 2014
NCT01619007 Completed Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy June 2012 July 2015
NCT02877251 Not yet recruiting Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease December 2023 December 2024
NCT04649489 Recruiting A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev April 19, 2021 March 31, 2028
NCT04156230 Recruiting Phase 2 Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis January 13, 2020 December 31, 2025
NCT04889326 Recruiting Collection of the Thrombo-VaxCov Cohort April 2, 2021 May 2023
NCT02810704 Recruiting Phase 4 Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement December 2016 July 2025
NCT02650453 Recruiting Ongoing Registry of Deep Venous Reconstructions September 2009 September 2029
NCT01042067 Suspended Safer Warfarin Treatment January 2010
NCT01406795 Terminated N/A The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses December 2010 December 2014
NCT02649023 Terminated Deep Venous Thrombosis After Hepatobiliopancreatic Surgery January 2016 April 2018
NCT00521885 Terminated N/A Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients September 2007 September 2009
NCT00539942 Terminated Phase 3 Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy April 2007 June 2010
NCT01051297 Terminated Obstructive Sleep Apnea and Venous Thromboembolism March 2009 May 2015
NCT00186745 Terminated N/A Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure March 2005 February 2016
NCT00872079 Terminated N/A Personalized Warfarin Dosing by Genomics and Computational Intelligence September 2008 September 2011
NCT02506985 Terminated Phase 4 XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis July 2015 June 29, 2016
NCT01717495 Unknown status Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures April 2013 April 2016
NCT04732299 Unknown status Staging and Prognosis of Deep Venous Thrombosis of Lower Extremities December 1, 2021 February 1, 2024
NCT03773939 Unknown status Risk Prediction of Venous Thromboembolism in Critically Ill March 27, 2015 October 1, 2021
NCT02597218 Unknown status Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. October 2015 February 2020
NCT02697123 Unknown status Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients January 2016 January 2024
NCT04036656 Unknown status Phase 1 Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers August 2019 May 2020
NCT02752984 Unknown status Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion April 2016 June 2018
NCT02062021 Unknown status Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease January 2014 June 2015
NCT04967573 Unknown status Phase 3 Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis August 1, 2021 December 31, 2023
NCT02238444 Unknown status Phase 4 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy September 1, 2014 September 30, 2019
NCT03001544 Unknown status Phase 1 Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer July 2015 June 2017
NCT01252420 Unknown status Phase 4 Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis November 2010 November 2014
NCT02264743 Unknown status Phase 4 Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy November 2013 November 2015
NCT02264964 Unknown status N/A Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis January 2015 December 2017
NCT01382550 Unknown status Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. March 1993
NCT01413464 Unknown status The Risk of Venous Clotting in Patients After Renal Transplant March 2011 September 2013
NCT02268630 Unknown status Long Term Outcomes of Venous Thromboembolism January 2014 October 2023
NCT00162435 Unknown status N/A Genetic Determinants of Warfarin Anticoagulation Effect August 2002 December 2020
NCT02343198 Unknown status N/A The Use of NMES as a Home-based Therapy Following Total Knee Arthroplasty August 2014 December 2015
NCT02414802 Unknown status N/A Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis December 2014 December 2017
NCT02767232 Withdrawn Phase 3 Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial July 2018 June 2023
NCT01164540 Withdrawn Phase 3 Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis February 2011 March 2013
NCT00808626 Withdrawn Phase 1/Phase 2 Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis December 2008 March 2017
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0004936
MeSH unique ID (MeSH (Medical Subject Headings))
D020246